The Characterization of Atrial Fibrillation and Prognostic Value of a Modified 4S-AF Scheme: A Report from the REGUEIFA Community Health Area Registry (Galician Intercentric Registry of Atrial Fibrillation)
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: The REGUEIFA registry aims to assess the contemporary treatment of patients with atrial fibrillation (AF) in the community health area of Galicia. Due to the prognostic relevance of anticoagulation status, we used it to differentiate patients by adding a category to the stroke domain of the 4S-AF score. Methods: A Cox proportional hazards analysis was used to identify the prognostic value of the modified 4S-AF score regarding mortality, cardiovascular mortality, and thromboembolic events. For bleeding events, we used a Poisson regression model to account for recurrent events. Results: When considering the stroke risk domain as a categorical variable, the risk stratification for all-cause mortality improved by more than 2 times (stroke risk: 2 vs. 1; hazard ratio (HR): 2.17; 95% confidence interval (CI): 1.03–4.55), p = 0.04). According to the Poisson regression model, the stroke risk domain was also an independent factor for hemorrhagic events (HR: 2.83; 95% CI 1.69–4.74, p < 0.001). For patients with permanent AF, the mortality rate was more than 2 times higher than that of patients with paroxysmal AF or their first episode of AF (HR: 2.53; 95% CI; 1.53–4.18); p < 0.001. Anticoagulation therapy was the only independent domain treatment associated with a reduction in all-cause mortality (HR: 0.41; 95% CI 0.19–0.89 p < 0.0023). Conclusions: The modification of the stroke risk score to reflect anticoagulation status may improve the characterization and stratification of overall mortality risk, as demonstrated in the contemporary AF cohort from the REGUEIFA study. The permanent form of AF was associated with a higher risk of overall mortality and cardiovascular mortality.
Source: Journal of Clinical Medicine
DOI: 10.3390/jcm14051483
Authors: Javier García Seara, Laila González Melchor, María Vázquez Caamaño, Emilio Fernández-Obanza Windcheid, Raquel Marzoa, Miriam Piñeiro Portela, Eva González Babarro, Pilar Cabanas Grandío, Olga Durán Bobín, Óscar Prada Delgado, Juliana Elices Teja, Evaristo Freire, Mario Gutiérrez Feijoo, Javier Muñiz, Francisco Gude, Eduardo Barge Caballero, Carlos González-Juanatey, on behalf of the REGUEIFA Investigators
Institutions: Instituto de Salud Carlos III, Centro de Investigación en Red en Enfermedades Cardiovasculares, Complejo Hospitalario Universitario de Santiago, Instituto de Investigación Sanitaria de Santiago, Servicio Gallego de Salud, Hospital Universitario Lucus Augusti, Complejo Hospitalario Universitario de Ferrol, Instituto de Investigación Biomédica de A Coruña, Hospital Montecelo, Complejo Hospitalario de Ourense, Universidade da Coruña, Centro de Investigación Biomédica en Red, Universidade de Santiago de Compostela
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,137
Funder: Daiichi-Sankyo
OpenAlex ID: W4407880397
